Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance

Key Takeaways LLY topped Q4 estimates as adjusted EPS touched $7.54 and revenues rose 43% to $19.3 billion.LLY saw GLP-1 demand surge, with Mounjaro and Zepbound sales jumping 110% and 123%, respectively.Eli Lilly guided 2026 revenues of $80-$83B and EPS of $33.50-$35.00.Eli Lilly and Company (LLY) reported fourth-quarter 2025 adjusted earnings per share (“EPS”) of $7.54, which beat the Zacks Consensus Estimate of $6.99 per share. Earnings rose 42% year over year.Revenues of $19.3 billion rose 43% year over ...